SAN DIEGO, May 19, 2022 /PRNewswire/ — Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase common stock in lieu of common stock to certain investors) and warrants to purchase shares of its common stock in an underwritten public offering. The …
Continue reading “Evofem Biosciences Announces Proposed Public Offering”